Ivosidenib in Treating Patients with Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/20 → 1/1/25

Funding

  • National Cancer Institute